Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients

ConclusionsThe post-treatment GH level might be a predictor for ICIs treatment in AGC patients.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research